Načítá se...

Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis

AIM: We investigated the chemotherapy effect of resectable colorectal cancer with liver metastasis (CRLM) on the function of intrahepatic immune cells. METHODS: We classified patients into adjuvant chemotherapy (bevacizumab+CapeOX) after hepatectomy group (group A) and neoadjuvant chemotherapy follo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Gastroenterol Surg
Hlavní autoři: Hirata, Fumihiro, Ishiyama, Kohei, Tanaka, Yuka, Kobayashi, Tsuyoshi, Hashimoto, Masakazu, Saeki, Yoshihiro, Ishida, Nobuki, Taguchi, Kazuhiro, Tanaka, Junko, Arihiro, Koji, Ohdan, Hideki
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139723/
https://ncbi.nlm.nih.gov/pubmed/30238080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12195
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!